Adiponectin and metformin additively attenuate IL1b-induced malignant potential of colon cancer

Endocrine-Related Cancer

Volumn 20, Issue 6, 2013, Pages 849-859

  Moon, Hyun Seuk ^a   Mantzoros, Christos S ^a,b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Adiponectin; Colon cancer; Interleukin 1b; Lkb1; Malignant potential; Metformin

Indexed keywords

ADIPONECTIN; INTERLEUKIN 1BETA; METFORMIN; PROTEIN P53;

ANIMAL CELL; ARTICLE; CELL CYCLE PROGRESSION; CELL LINE; CELL PROLIFERATION; COLON CANCER; CYCLIN E2 GENE; GENE; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; P21 GENE; P27 GENE;

ADIPONECTIN; COLON CANCER; INTERLEUKIN 1Β; LKB1; MALIGNANT POTENTIAL; METFORMIN;

ADIPONECTIN; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; BLOTTING, WESTERN; CELL ADHESION; CELL CYCLE; CELL PROLIFERATION; COLONIC NEOPLASMS; FLOW CYTOMETRY; HUMANS; HYPOGLYCEMIC AGENTS; IMMUNOENZYME TECHNIQUES; INTERLEUKIN-1BETA; METFORMIN; MICE; PROTEIN-SERINE-THREONINE KINASES; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; STAT3 TRANSCRIPTION FACTOR; TUMOR CELLS, CULTURED;

EID: 84891462564     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1530/ERC-13-0240     Document Type: Article

References (32)

1. Algire C, Amrein L, Panasci L & Pollak M 2010 Metformin blocks the stimulative effect of a high-energy diet on colon carcinoma growth in vivo and is associated with reduced expression of fatty acid synthase. Endocrine-Related Cancer 17 351-360. (doi:10.1677/ERC-09-0252)
2. Ben Sahra I, Laurent K, Loubat A, Giorgetti-Peraldi S, Colosetti P, Auberger P, Tanti JF, Le Marchand-Brustel Y & Bost F 2008 The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level. Oncogene 27 3576-3586. (doi:10.1038/ sj.onc.1211024)
3. Calle EE & Kaaks R 2004 Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nature Reviews. Cancer 4 579-591. (doi:10.1038/nrc1408)
4. Dalamaga M, Diakopoulos KN & Mantzoros CS 2012 The role of adiponectin in cancer: a review of current evidence. Endocrine Reviews 33 547-594. (doi:10.1210/er.2011-1015)
5. Dowling RJ, Zakikhani M, Fantus IG, Pollak M & Sonenberg N 2007 Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells. Cancer Research 67 10804-10812. (doi:10.1158/0008-5472.CAN-07-2310)
6. Ealey KN & Archer MC 2009 Elevated circulating adiponectin and elevated insulin sensitivity in adiponectin transgenic mice are not associated with reduced susceptibility to colon carcinogenesis. International Journal of Cancer 124 2226-2230. (doi:10.1002/ijc.24187)
7. Gotlieb WH, Saumet J, Beauchamp MC, Gu J, Lau S, PollakMN & Bruchim I 2008 In vitro metformin anti-neoplastic activity in epithelial ovarian cancer. Gynecologic Oncology 110 246-250. (doi:10.1016/j.ygyno.2008. 04.008)
8. Gunter MJ & Leitzmann MF 2006 Obesity and colorectal cancer: epidemiology, mechanisms and candidate genes. Journal of Nutritional Biochemistry 17 145-156. (doi:10.1016/j.jnutbio.2005.06.011)
9. Hardie DG 2005 New roles for the LKB1/AMPK pathway. Current Opinion in Cell Biology 17 167-173. (doi:10.1016/j.ceb.2005.01.006)
10. Imamura K, Ogura T, Kishimoto A, KaminishiM & Esumi H 2011 Cell cycle regulation via p53 phosphorylation by a 50-AMP activated protein kinase activator, 5-Aminoimidazole-4-carboxamide-1-b-D-ribofuranoside, in a human hepatocellular carcinoma cell line. Biochemical and Biophysical Research Communications 287 562-567. (doi:10.1006/bbrc. 2001.5627)
11. Isakovic A, Harhaji L, Stevanovic D, Markovic Z, Sumarac-Dumanovic M, Starcevic V, Micic D & Trajkovic V 2007 Dual antiglioma action of metformin: cell cycle arrest and mitochondria-dependent apoptosis. Cellular and Molecular Life Sciences 64 1290-1302. (doi:10.1007/s00018- 007-7080-4)
12. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T & Thun MJ 2008 Cancer statistics. CA: A Cancer Journal for Clinicians 58 71-96. (doi:10.3322/ CA.2007.0010)
13. Kato S, Onda M, Yamada S, Matsuda N, Tokunaga A & Matsukura N 2001 Association of the interleukin-1b genetic polymorphism and gastric cancer risk in Japanese. Journal of Gastroenterology 36 696-699. (doi:10.1007/s005350170033)
14. Kubota N, Yano W, Kubota T, Yamauchi T, Itoh S, Kumagai H, Kozono H, Takamoto I, Okamoto S, Shiuchi T et al. 2007 Adiponectin stimulates AMP-Activated protein kinase in the hypothalamus and increases food intake. Cell Metabolism 6 55-68. (doi:10.1016/ j.cmet.2007.06.003)
15. Lee KM, Park SK, Hamajima N, Tajima K, Choi JY, Noh DY, Ahn SH, Yoo KY, Hirvonen A & Kang D 2006 Genetic polymorphisms of interleukin-1b (IL-1B) and IL-1 receptor antagonist (IL-1RN) and breast cancer risk in Korean women. Breast Cancer Research and Treatment 96 197-202. (doi:10.1007/s10549-005-9079-6)
16. LeRoith D, Novosyadlyy R, Gallagher EJ, Lann D, Vijayakumar A & Yakar S 2008 Obesity and type 2 diabetes are associated with an increased risk of developing cancer and a worse prognosis; epidemiological and mechanistic evidence. Experimental and Clinical Endocrinology & Diabetes 116 (Suppl 1) S4-S6. (doi:10.1055/s-2008-1081488)
17. Malki A & Youssef A 2011 Antidiabetic drug metformin induces apoptosis in human MCF breast cancer via targeting ERK signaling. Oncology Research 19 275-285. (doi:10.3727/096504011X13021877989838)
18. Melani C, Chiodoni C, Forni G & Colombo MP 2003 Myeloid cell expansion elicited by the progression of spontaneous mammary carcinomas in c-erbB-2 transgenic BALB/c mice suppresses immune reactivity. Blood 102 2138-2145. (doi:10.1182/blood-2003-01-0190)
19. Moon HS, Chamberland JP, Aronis K, Tseleni-Balafouta S & Mantzoros CS 2011 Direct role of adiponectin and adiponectin receptors in endometrial cancer: in vitro and ex vivo studies in humans. Molecular Cancer Therapeutics 10 2234-2243. (doi:10.1158/1535-7163.MCT-11-0545)
20. MoonHS, LiuX,Nagel JM,ChamberlandJP, DiakopoulosKN, BrinkoetterMT, Hatziapostolou M, Wu Y, Robson SC, Iliopoulos D et al. 2013 Salutary effects of adiponectin on colon cancer: in vivo and in vitro studies in mice. Gut 62 561-570. (doi:10.1136/gutjnl-2012-302092)
21. Oshita T, Shigemasa K, Nagai N & Ohama K 2002 p27, cyclin E, and CDK2 expression in normal and cancerous endometrium. International Journal of Oncology 21 737-743.
22. Rattan R, Giri S, Singh AK & Singh I 2005 5-Aminoimidazole-4- carboxamide-1-b-D-ribofuranoside inhibits cancer cell proliferation in vitro and in vivo via AMP-Activated protein kinase. Journal of Biological Chemistry 280 39582-39593. (doi:10.1074/jbc.M507443200)
23. Rattan R, Giri S, Hartmann LC & Shridhar V 2011 Metformin attenuates ovarian cancer cell growth in an AMP-kinase dispensable manner. Journal of Cellular and Molecular Medicine 15 166-178. (doi:10.1111/ j.1582-4934.2009. 00954.x)
24. Snider AJ, Orr-Gandy KA & Obeid LM 2010 Sphingosine kinase: role in regulation of bioactive sphingolipid mediators in inflammation. Biochimie 92 707-715. (doi:10.1016/j.biochi.2010.02.008)
25. Thakkar B, Aronis KN, Vamvini MT, Shields K & Mantzoros CS 2013 Metformin and sulfonylureas in relation to cancer risk in type II diabetes patients: a meta-Analysis using primary data of published studies. Metabolism 62 922-934. (doi:10.1016/j.metabol.2013.01.014)
26. Wei EK, Giovannucci E, Fuchs CS, Willett WC & Mantzoros CS 2005 Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study. Journal of the National Cancer Institute 97 1688-1694. (doi:10.1093/jnci/dji376)
27. Wu B, Li S, Sheng L, Zhu J, Gu L, Shen H, La D, Hambly BD, Bao S & Di W 2012 Metformin inhibits the development and metastasis of ovarian cancer. Oncology Reports 28 903-908. (doi:10.3892/or.2012.1890)
28. Xiang X, Saha AK, Wen R, Ruderman NB & Luo Z 2004 AMP-Activated protein kinase activators can inhibit the growth of prostate cancer cells by multiple mechanisms. Biochemical and Biophysical Research Communications 321 161-167. (doi:10.1016/j.bbrc.2004. 06.133)
29. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K et al. 2002 Adiponectin stimulates glucose utilization and fatty-Acid oxidation by activating AMP-Activated protein kinase. Nature Medicine 8 1288-1295. (doi:10.1038/nm788)
30. Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, Kita S, Sugiyama T, Miyagishi M, Hara K, Tsunoda M et al. 2003 Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423 762-769. (doi:10.1038/nature01705)
31. Yu H, Kortylewski M & Pardoll D 2007 Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment. Nature Reviews. Immunology 7 41-51. (doi:10.1038/nri1995)
32. Zakikhani M, Dowling R, Fantus IG, Sonenberg N & Pollak M 2006 Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells. Cancer Research 66 10269-10273. (doi:10.1158/0008-5472. CAN-06-1500)